Orostat 8%
FDA Label NDC 10129-006

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Gingi-pak A Division Of The Belport for the product Orostat 8% (NDC 10129-006). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, purpose, description, inactive ingredient, keep out of reach if children, storage, uses, do not use, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.